Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)75-80
JournalAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Volume1
Issue number1
DOIs
Publication statusPublished - 2015

Cite this